Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.07.003Source: DataRank Database

Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies is a research paper published in Clinical Lung Cancer (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.18)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Yuezhu Wang ORCID,Caroline B. Dixon,Ralph B. D’Agostino ORCID,Yin Liu ORCID,Jimmy Ruiz ORCID

Live enrichment

PubMed:39095235 PMC:PMC11588554 OpenAlex:https://openalex.org/W4400618472

National Institutes of Health

Grant: R37CA230451

National Institutes of Health

Grant: P30CA012197

National Institutes of Health

Grant: P30CA082709

NCATS NIH HHS

Grant: K12 TR004931

FWCI

0.18

Citation Percentile

0.5%

Citation Trend

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11588554/pdf/nihms-2008804.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525730424001414?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525730424001414?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11588554/

Fields of Study

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

MeSH Terms

Immune Checkpoint InhibitorsAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungFemaleHumansImmunotherapyLung NeoplasmsMaleMiddle AgedMutationRetrospective Studies

Keywords

MedicineLimitingLung cancerOncologyIncidence (geometry)Internal medicineAdverse effectIntensive care medicineMutationSequencingImmunotherapyNonsmall Cell Lung CancerImmune Related Adverse Effect